F. Karimi, J. Barletta, B. Långström
FULL PAPER
General Method: A capped vial (1 mL) containing a solution of
tris(dibenzylideneacetone)palladium(0) (2.1 mg, 2.3 μmol) and tri-
o-tolylphosphane (16 mg, 52.6 μmol) in anhydrous DMSO
Acc. Chem. Res. 1997, 30, 181–188; c) B. Långström, T.
Kilhberg, M. Bergström, G. Antoni, M. Björkman, B. Forn-
gren, T. Forngren, P. Hartvig, K. Markides, U. Yngve, M.
Ögren, Acta Chem. Scand. 1999, 59, 651–669; d) M. Bergström,
A. Grahnén, B. Långström, Eur. J. Clin. Pharmacol. 2003, 59,
(500 μL) was flushed with argon. The reaction mixture was kept at
room temperature for 10 min. The appropriate halide (18 μmol)
was added and the resulting mixture kept at room temperature for
an additional 5 min. The reaction mixture was filtered (ThermoHy-
persil F2513-3, PTFE syringe filter 0.45 μm) before addition of the
organostannane just before injection into the micro-autoclave pre-
357–366.
[
2] a) R. J. Davenport, J. A. McCarron, K. Dowsett, D. R. Turton,
K. G. Poole, V. W. Pike, J. Labelled Compd. Radiopharm. 1997,
40, S309–S311; b) C. Perrio-Huard, C. Aubert, M. C. Lasne, J.
Chem. Soc., Perkin Trans. 1 2000, 3, 311–316.
11
charged with [ C]carbon monoxide. The micro-autoclave was
heated at the desired temperature for 5 min. The crude product was
transferred to a vial (3 mL) at reduced pressure. The radioactivity
was measured before and after the vial was flushed with nitrogen.
The identity of the crude product was determined by analytical LC
using a reference compound.
[3] a) M. R. Kilbourn, P. A. Jarabek, M. J. Welch, J. Chem. Soc.,
Chem. Commun. 1983, 861–862; b) S. K. Zeisler, M. Nader, A.
Theobald, F. Oberdorfer, Appl. Radiat. Isot. 1997, 48, 1091–
1095.
[
4] T. Kihlberg, B. Långström, “Method and Apparatus for Pro-
11
duction and Use of [ C]carbon monoxide in labelling synthe-
sis”, Swedish Pending Patent Application N. 0102174-0.
[
5] a) T. Kilhberg, B. Långström, J. Org. Chem. 1999, 64, 9201–
Compounds 1–5, 7, 8, 11, 12, 16 and 18 were analysed using the
9205; b) F. Karimi, B. Långström, J. Chem. Soc., Perkin Trans.
following HPLC method: Solvent A/B (70:30), linear gradient to
1
2002, 2111–2115; c) F. Karimi, B. Långström, Eur. J. Org.
–
1
0
:100 during 6 min, then 7 min at 100% B, flow 1.5 mLmin .
Chem. 2003, 2132–2137; d) F. Karimi, B. Långström, Org. Bio-
mol. Chem. 2003, 1, 541–546; e) F. Karimi, T. Kilhberg, B.
Långström, J. Chem. Soc., Perkin Trans. 1 2001, 1528–1531; f)
F. Karimi, B. Långström, J. Chem. Soc., Perkin Trans. 1 2002,
Compounds 6, 9, 10, 13–15, 17 and 19 were analysed using the
following HPLC method: Solvent A/B (90:10), linear gradient to
–
1
0
:100 during 8 min, then 5 min at 100% B, flow 1.5 mLmin .
2256–2259; g) O. Rahman, T. Kihlberg, B. Långström, J. Chem.
Compound 20 was analysed using the following HPLC method:
Solvent C/B (95:5), isocratic at 5% B for 5 min, linear gradient to
Soc., Perkin Trans. 1 2002, 2699–2703; h) O. Rahman, T.
Kihlberg, B. Långström, J. Org. Chem. 2003, 68, 3558–3562; i)
T. Kilhberg, F. Karimi, B. Långström, J. Org. Chem. 2002, 67,
–
1
0
:100 during 8 min, then 1 min at 100% B, flow 1.5 mLmin .
(13
C)4Ј-Aminoacetophenone (6): Tris(dibenzylideneacetone)palla-
dium(0) (2.1 mg, 2.3 μmol), tri-o-tolylphosphane (16 mg,
2.6 μmol), 4-iodoaniline (23; 5 mg, 22.8 μmol) and tetramethyltin
140 μL, 1.01 mmol) were used. The reaction was performed as de-
3
687–3692.
6] Y. Andersson, B. Långström, J. Chem. Soc., Perkin Trans. 1
995, 287–289.
[
1
5
(
[7] P. Lidström, T. Kihlberg, B. Långström, J. Chem. Soc., Perkin
Trans. 1 1997, 2701–2706.
[8] J. Barletta, M. Björkman, M. Ögren, B. Langström, J. Labelled
Compd. Radiopharm. 2001, 44, S979–S980.
1
1
scribed before but the micro-autoclave was pre-charged with [ C]
carbon monoxide and ( C)carbon monoxide, and then heated at
20 °C for 25 min. 4Ј-Aminoacetophenone was purified using the
13
[
9] M. Nader, A. Theobald, S. K. Zeisler, S. K. Oberdorfer, J. Lab-
elled Compd. Radiopharm. 2001, 40, S732.
1
following preparative HPLC method: solvent A/D (70:30), isocratic
at 30% B for 1 min, linear gradient to 0.100 during 7 min, then
[10] a) O. Rahman, T. Kihlberg, B. Långström, Eur. J. Org. Chem.
2004, 474–478; b) O. Rahman, J. Llop, B. Långström, Eur. J.
9
min at 100% D. The radioactive fraction was collected and evapo-
Org. Chem. 2004, manuscript accepted for publication.
11] H. E. Zaugg, J. Am. Chem. Soc. 1961, 83, 837.
rated under reduced pressure to yield the desired compound (89%).
[
13
CNMR (400 MHz, CDCl
3
): δ = 196.7 ppm.
[12] M. Suzuki, M. Björkman, Y. Andersson, B. Långström, Y. Wa-
tanabe, R. Noyori, Chem. Eur. J. 1997, 3, 12, 2039–2042.
13] C. A. Tolman, Chem. Rev. 1977, 77, 313–348.
[
Acknowledgments
[14] D. R. Christman, R. D. Finn, K. I. Kalstrom, A. P. Wolf, Int.
J. Appl. Radiat. Isot. 1975, 26, 435–442.
[
15] B. Långström, H. Lundquist, Radiochem. Radioanal. Lett.
979, 41, 375.
We thank the Swedish Research Council for financial support
grant K3464) for B.L.
1
(
[
16] P. Bjurling, R. Reineck, G. Westerberg, A. D. Gee, J. Sutcliffe,
B. Långström, Proc. 6th workshop on Targetry and Target
Chemistry, Vancouver, Canada, 1995, 282–284.
Received: December 14, 2004
[
1] a) C. Comar, Developments in Nuclear Medicine, Kluwer Aca-
demic Publishers (Dordrecht), 1995; b) J. S. Fowler, A. P. Wolf,
2378
© 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
Eur. J. Org. Chem. 2005, 2374–2378